TTY Biopharm Company Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | Outperform |
9
|
$146.14 | $174.55 | 16.33% | 3 | $356.43B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£119.88 | £165.99 | 35.93% | 16 | £186.43B |
| NOVN | Novartis | Hold |
10
|
CHF89.50 | CHF105.00 | 20.25% | 9 | CHF181.47B |
| ABT | Abbott Laboratories | Outperform |
9
|
$107.53 | $118.92 | 17.64% | 7 | $186.15B |
| PFE | Pfizer | Outperform |
2
|
$25.40 | $32.87 | 20.08% | 6 | $147.23B |
| SAN | Sanofi | Outperform |
16
|
91.23€ | 102.80€ | 19.48% | 9 | 109.51€B |
| CSL | CSL | Outperform |
12
|
$273.30 | $205.51 | -25.66% | 5 | $130.23B |
| GSK | GSK | Outperform |
12
|
£16.53 | £17.30 | 17.97% | 12 | £67.54B |
| BAX | Baxter International Inc | Outperform |
17
|
$40.13 | $44.86 | 12.14% | 5 | $20.10B |
| 1093 | CSPC Pharmaceutical Group | Buy |
18
|
HK$6.60 | HK$9.50 | 40.91% | 6 | HK$69.45B |
| 4142 | Adimmune | - |
10
|
NT$31.05 | NT$55.00 | -100.00% | 0 | NT$14.08B |
| PSTV | Plus Therapeutics | Outperform |
11
|
$1.69 | $11.00 | 373.37% | 2 | $6.97M |